NeuroSense Therapeutics Ltd. Ordinary Shares

NRSN XNAS

Historical Short Interest Share

American Express® Business Gold Card

Earn Up to 200K Membership Rewards® Points

4X on your top 2 spending categories. Transfer to 20+ airline & hotel partners. Terms apply.

Learn More

Market Cap

22M

Short interest (Jul 15)

1.5%

Net Short (Jul 27 ): 0.0%

Borrow Fee

5.32%

↑ 0.5%

Available Shares

400K

↑ 17.9%

Price Chart

Company Overview

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.

Company Info

Exchange: NASDAQ

CIK: 0001875091

Asset Type: CS

Market Data

Market Cap: $21,735,697

Employees: 16

Status: Active

Short Interest

Current Borrow Fee 5.32%

Range: 5.32% - 5.32%

Available Shares 400K

Range: 150K - 700K

Recent Changes

Fee Change: ↓ 1.4%

Available Change: ↑ 27.8%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime